Kristine Stavås Skistad and Helene Marie Fossesholm are two of Norway's largest langrennstalenter, and in the weekend they won two more races in the Norgescupen for juniors.
In the day they choose, however, to send out a press release about the use of medical preparations, after that several media outlets have contacted the two langrennstalentene about this.Beating Weng and crushes junior athletes – the 16-year-old Helene can be Norway's next storløper
the Newspaper has been one of the media who have been familiar with this for a long time and has, in consultation with the family chosen to not write anything about this before now.
"Langrennsløperne Helene Marie Fossesholm and Kristine Stavås Skistad (both on Skiforbundets juniorlandslag) have, independently of each other, and with completely different starting point, had questions about the use of medication in conjunction with hormonbehandlinger linked to growth failure.", writes the Norwegian ski federation in the press release that was sent out Monday morning.Not in conflict with antidopingreglene Stavås Skistad trainer that Northug and reminiscent of Stina Nilsson
Associated shall also have been contacted by the media about hormonbehandlingene, and in consultation with the two langrennsløpernes families agreed to tell about these treatments through the press release.
the Information provided is of a very private character, and the two tells us about treatments to show that they are not in conflict with the Wada antidopingreglement, it says in the message.
17-year-old Fossesholm, which by many is predicted a very bright future in the langrennssporten, were treated with the growth hormones in the period December 2014 to septemer 2017.
"Helene has been followed up by the pediatrician at the hospital from the time she was 8-9 years old because she was very small in stature. When she was 13,5 years she was 137,5 cm high and had abnormal vekstutvikling. She was therefore treated with growth hormone. Helene is now 151 cm tall.", type NSF in the press release.
"Helenes treatment including a remedy that is on the Wada forbudsliste. There are very stringent requirements for approval and use of such medication in the Uk. It was, therefore, applied for a medical exemption (TUE) for this at anti-doping Norway when this was required. The application was granted by anti-doping Norway and she fulfilled all The criteria.", called it on.Kristine shocked the elite on Tuesday: - It is obviously a good season A very private matter,
Kristine Stavås Skistad is there to talk about other preparations, and quite other reasons for the treatment.
"In 2012 got Kristine tablets Ethinyl estradiol and Primolut to speed up puberty, and to have a controlled growth. For Skistad this is a very private matter. Kristines treatment was carried out with preparations that are not on the Wada forbudsliste.", type NSF in the press release.
Stavås Skistad struck in earnest through in langrennssirkuset under the national sesongåpningen at Beitostølen in november. Where she was the number two in the sprint, behind the sovereign Maiken Caspersen Falla.
In Lillehammer, norway, two weeks later, she was the number five in the world cup at the same distance. It was her second race in the world cup after his debut in Drammen last march.
Neither the athletes or families want to comment on the information beyond what it says in the press release, and medieansvarlig in the Norwegian ski federation, Gro Eide, can't say if they have felt the pressure to tell if the treatments in the form of this press release.
- We relate to what it says in this press release, " says Eide, to the Norwegian newspaper Dagbladet, and enlightens at the same time that she does not know how many inquiries the families have been given about this.
According to the medical responsible in the Norwegian ski federation, Ola Rønsen, were both athletes treated by specialists in hospitals in Norway.Therese Johaug amazed his 16-year-old heir